National Human Genome Research Institute; Notice of Closed Meeting, 48713-48714 [2020-17647]

Download as PDF Federal Register / Vol. 85, No. 156 / Wednesday, August 12, 2020 / Notices (1) Respondent agreed to exclude himself voluntarily for a period of ten (10) years beginning on July 21, 2020, from any contracting or subcontracting with any agency of the United States Government and from eligibility for or involvement in nonprocurement programs of the United States Government referred to as ‘‘covered transactions’’ pursuant to HHS’s Implementation (2 CFR part 376) of OMB Guidelines to Agencies on Governmentwide Debarment and Suspension, 2 CFR part 180 (collectively the ‘‘Debarment Regulations’’); (2) Respondent agreed to exclude himself voluntarily from serving in any advisory capacity to PHS including, but not limited to, service on any PHS advisory committee, board, and/or peer review committee, or as a consultant for a period of ten (10) years, beginning on July 21, 2020; and (3) as a condition of the Agreement, Respondent will request that the following paper be corrected or retracted in accordance with 42 CFR 93.407(a)(1): • Mol. Cancer Ther. 2008 Feb;7(2):341–9 Dated: August 7, 2020. Elisabeth A. Handley, Director, Office of Research Integrity, Office of the Assistant Secretary for Health. [FR Doc. 2020–17602 Filed 8–11–20; 8:45 am] BILLING CODE 4150–31–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute on Aging; Notice of Closed Meeting khammond on DSKJM1Z7X2PROD with NOTICES Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute on Aging Special Emphasis Panel; AD Analysis. Date: September 4, 2020. Time: 2:00 p.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institute on Aging, Gateway Building, 7201 Wisconsin Avenue, Bethesda, MD 20892 (Video Meeting). Contact Person: Nijaguna Prasad, Ph.D., Scientific Review Officer, Scientific Review Branch, National Institute on Aging, National Institutes of Health, 7201 Wisconsin Avenue, Gateway Building, Suite 2W200, Bethesda, VerDate Sep<11>2014 16:37 Aug 11, 2020 Jkt 250001 MD 20892, (301) 496–9667, nijaguna.prasad@nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.866, Aging Research, National Institutes of Health, HHS) Dated: August 6, 2020. Miguelina Perez, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2020–17586 Filed 8–11–20; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Fogarty International Center; Notice of Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of a meeting of the Fogarty International Center Advisory Board. The meeting will be open to the public, with attendance limited to space available. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the Contact Person listed below in advance of the meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute clearly unwarranted invasion of personal privacy. Name of Committee: Fogarty International Center Advisory Board. Date: September 10–11, 2020. Closed: September 10, 2020, 12:00 p.m. to 3:00 p.m. Agenda: To review and evaluate grant applications. Place: Fogarty International Center, National Institutes of Health, 31 Center Drive, Bethesda, MD 20892 (Virtual Meeting). Open: September 11, 2020, 12:00 p.m. to 3:00 p.m. Agenda: Update and discussion of current and planned FIC activities. Place: Fogarty International Center, National Institutes of Health, 31 Center Drive, Bethesda, MD 20892 (Virtual Meeting). Meeting Access: https://www.fic.nih.gov/ About/Advisory/Pages/default.aspx. Contact Person: Kristen Weymouth, Executive Secretary, Fogarty International Center, National Institutes of Health, 31 Center Drive, Room B2C02, Bethesda, MD 20892–7952, (301) 496–1415, kristen.weymouth@nih.gov. PO 00000 Frm 00049 Fmt 4703 Sfmt 4703 48713 Any interested person may file written comments with the committee by forwarding the statement to the Contact Person listed on this notice. The statement should include the name, address, telephone number and when applicable, the business or professional affiliation of the interested person. Information is also available on the Institute’s/Center’s home page: https:// www.fic.nih.gov/About/Advisory/Pages/ default.aspx where an agenda and additional information for the meeting will be posted when available. (Catalogue of Federal Domestic Assistance Program Nos. 93.106, Minority International Research Training Grant in the Biomedical and Behavioral Sciences; 93.154, Special International Postdoctoral Research Program in Acquired Immunodeficiency Syndrome; 93.168, International Cooperative Biodiversity Groups Program; 93.934, Fogarty International Research Collaboration Award; 93.989, Senior International Fellowship Awards Program, National Institutes of Health, HHS) Dated: August 6, 2020. Miguelina Perez, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2020–17589 Filed 8–11–20; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Human Genome Research Institute; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Center for Inherited Disease Research Access Committee Grant Review. Date: September 11, 2020. Time: 11:30 a.m. to 2:30 p.m. Agenda: To review and evaluate grant applications. Place: National Human Genome Research Institute, National Institutes of Health, 6700B Rockledge Drive, Room 3185, Bethesda, MD 20892 (Telephone Conference Call). Contact Person: Barbara J. Thomas, Ph.D., Scientific Review Officer, Scientific Review Branch, National Human Genome Research E:\FR\FM\12AUN1.SGM 12AUN1 48714 Federal Register / Vol. 85, No. 156 / Wednesday, August 12, 2020 / Notices khammond on DSKJM1Z7X2PROD with NOTICES Institute, National Institutes of Health, 6700B Rockledge Drive, Room 3185, Bethesda, MD 20892–9306, 301–402–0838, barbara.thomas@nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.172, Human Genome Research, National Institutes of Health, HHS) Department of Housing and Urban Development Act (42 U.S.C. 3535(q)), which provides that: 1. Any waiver of a regulation must be in writing and must specify the grounds for approving the waiver; 2. Authority to approve a waiver of a Dated: August 7, 2020. regulation may be delegated by the Ronald J. Livingston, Jr., Secretary only to an individual of Program Analyst, Office of Federal Advisory Assistant Secretary or equivalent rank, Committee Policy. and the person to whom authority to [FR Doc. 2020–17647 Filed 8–11–20; 8:45 am] waive is delegated must also have authority to issue the particular BILLING CODE 4140–01–P regulation to be waived; 3. Not less than quarterly, the Secretary must notify the public of all DEPARTMENT OF HOUSING AND waivers of regulations that HUD has URBAN DEVELOPMENT approved, by publishing a notice in the [Docket No. FR–6210–N–01] Federal Register. These notices (each covering the period since the most Notice of Regulatory Waiver Requests recent previous notification) shall: Granted for the First Quarter of a. Identify the project, activity, or Calendar Year 2020 undertaking involved; b. Describe the nature of the provision AGENCY: Office of the General Counsel, waived and the designation of the Housing and Urban Development provision; (HUD). c. Indicate the name and title of the ACTION: Notice. person who granted the waiver request; SUMMARY: Section 106 of the Department d. Describe briefly the grounds for of Housing and Urban Development approval of the request; and Reform Act of 1989 (the HUD Reform e. State how additional information Act) requires HUD to publish quarterly about a particular waiver may be Federal Register notices of all obtained. Section 106 of the HUD Reform Act regulatory waivers that HUD has also contains requirements applicable to approved. Each notice covers the quarterly period since the previous waivers of HUD handbook provisions Federal Register notice. The purpose of that are not relevant to the purpose of this notice is to comply with the this notice. This notice follows procedures requirements of section 106 of the HUD provided in HUD’s Statement of Policy Reform Act. This notice contains a list on Waiver of Regulations and Directives of regulatory waivers granted by HUD issued on April 22, 1991 (56 FR 16337). during the period beginning on January 1, 2020 and ending on March 31, 2020. In accordance with those procedures and with the requirements of section FOR FURTHER INFORMATION CONTACT: For 106 of the HUD Reform Act, waivers of general information about this notice, regulations are granted by the Assistant contact Aaron Santa Anna, Acting Secretary with jurisdiction over the Associate General Counsel for Legislation and Regulations, Department regulations for which a waiver was requested. In those cases in which a of Housing and Urban Development, General Deputy Assistant Secretary 451 Seventh Street SW, Room 10276, Washington, DC 20410–0500, telephone granted the waiver, the General Deputy Assistant Secretary was serving in the 202–708–3055 (this is not a toll-free absence of the Assistant Secretary in number). Persons with hearing- or accordance with the office’s Order of speech-impairments may access this number through TTY by calling the toll- Succession. This notice covers waivers of free Federal Relay Service at 800–877– regulations granted by HUD from 8339. For information concerning a January 1, 2020 through March 31, 2020. particular waiver that was granted and For ease of reference, the waivers for which public notice is provided in granted by HUD are listed by HUD this document, contact the person program office (for example, the Office whose name and address follow the of Community Planning and description of the waiver granted in the Development, the Office of Fair Housing accompanying list of waivers that have and Equal Opportunity, the Office of been granted in the first quarter of Housing, and the Office of Public and calendar year 2020. Indian Housing, etc.). Within each program office grouping, the waivers are SUPPLEMENTARY INFORMATION: listed sequentially by the regulatory Section 106 of the HUD Reform Act section of title 24 of the Code of Federal added a new section 7(q) to the VerDate Sep<11>2014 16:37 Aug 11, 2020 Jkt 250001 PO 00000 Frm 00050 Fmt 4703 Sfmt 4703 Regulations (CFR) that is being waived. For example, a waiver of a provision in 24 CFR part 58 would be listed before a waiver of a provision in 24 CFR part 570. Where more than one regulatory provision is involved in the grant of a particular waiver request, the action is listed under the section number of the first regulatory requirement that appears in 24 CFR and that is being waived. For example, a waiver of both § 58.73 and § 58.74 would appear sequentially in the listing under § 58.73. Waiver of regulations that involve the same initial regulatory citation are in time sequence beginning with the earliest-dated regulatory waiver. Should HUD receive additional information about waivers granted during the period covered by this report (the first quarter of calendar year 2020) before the next report is published (the second quarter of calendar year 2020), HUD will include any additional waivers granted for the first quarter in the next report. Accordingly, information about approved waiver requests pertaining to HUD regulations is provided in the Appendix that follows this notice. The Principal Deputy General Counsel, Michael B. Williams, having reviewed and approved this document, is delegating the authority to electronically sign this document to submitter, Samuel Pearson-Moore, who is the Federal Register Liaison for HUD, for purposes of publication in the Federal Register. Dated: August 7, 2020. Samuel Pearson-Moore, Federal Register Liaison for the Department of Housing and Urban Development. Appendix Listing of Waivers of Regulatory Requirements Granted by Offices of the Department of Housing and Urban Development January 1, 2020 Through March 31, 2020 Note to Reader: More information about the granting of these waivers, including a copy of the waiver request and approval, may be obtained by contacting the person whose name is listed as the contact person directly after each set of regulatory waivers granted. The regulatory waivers granted appear in the following order: I. Regulatory waivers granted by the Office of Community Planning and Development. II. Regulatory waivers granted by the Office of Fair Housing and Equal Opportunity. III. Regulatory waivers granted by the Office of Housing. E:\FR\FM\12AUN1.SGM 12AUN1

Agencies

[Federal Register Volume 85, Number 156 (Wednesday, August 12, 2020)]
[Notices]
[Pages 48713-48714]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-17647]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Human Genome Research Institute; Notice of Closed 
Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: Center for Inherited Disease Research Access 
Committee Grant Review.
    Date: September 11, 2020.
    Time: 11:30 a.m. to 2:30 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Human Genome Research Institute, National 
Institutes of Health, 6700B Rockledge Drive, Room 3185, Bethesda, MD 
20892 (Telephone Conference Call).
    Contact Person: Barbara J. Thomas, Ph.D., Scientific Review 
Officer, Scientific Review Branch, National Human Genome Research

[[Page 48714]]

Institute, National Institutes of Health, 6700B Rockledge Drive, 
Room 3185, Bethesda, MD 20892-9306, 301-402-0838, 
[email protected].

(Catalogue of Federal Domestic Assistance Program Nos. 93.172, Human 
Genome Research, National Institutes of Health, HHS)

    Dated: August 7, 2020.
Ronald J. Livingston, Jr.,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2020-17647 Filed 8-11-20; 8:45 am]
BILLING CODE 4140-01-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.